Risk factors for local recurrence after lobectomy and lymph node dissection in patients with non-small cell lung cancer: Implications for adjuvant therapy-Reference-Cited by-同舟云学术

Risk factors for local recurrence after lobectomy and lymph node dissection in patients with non-small cell lung cancer: Implications for adjuvant therapy

Published:2018-01 Issue: Volume:115 Page:28-33
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Isaka Mitsuhiro,Kojima Hideaki,Takahashi Shoji,Omae Katsuhiro,Ohde Yasuhisa

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference27 articles.

1. Thoracic and cardiovascular surgery in Japan during 2012: annual report by The Japanese Association for Thoracic Surgery;Committee for Scientific Affairs;Gen. Thorac. Cardiovasc. Surg.,2014

2. Japanese lung cancer registry study of 11,663 surgical cases in 2004: demographic and prognosis changes over decade;Sawabata;J. Thorac. Oncol.,2011

3. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group;Pignon;J. Clin. Oncol.,2008

4. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial;Douillard;Lancet Oncol.,2006

5. Impact of Postoperative Radiation Therapy on Survival in Patients With Complete Resection and Stage I, II, or IIIA Non–Small-Cell Lung Cancer Treated With Adjuvant Chemotherapy: The Adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment patterns and clinical outcomes of patients with resectable non–small cell lung cancer receiving neoadjuvant immunochemotherapy: A large-scale, multicenter, real-world study (NeoR-World);The Journal of Thoracic and Cardiovascular Surgery;2024-02

2. Prognostic value of preoperative circulating tumor DNA in non-small cell lung cancer: a systematic review and meta-analysis;Journal of Cancer Research and Clinical Oncology;2024-01

3. Prognostic factors of resectable anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer (NSCLC) patients: a retrospective analysis based on a single center;Translational Lung Cancer Research;2024-01

4. Analysis of Factors Affecting Lymph Node Resection in Non-Small Cell Lung Cancer with Tumor Size ≤ 2 cm;Advances in Clinical Medicine;2024

5. Meta-Analysis of Rates and Risk Factors for Local Recurrence in Surgically Resected Patients With NSCLC and Differences Between Asian and Non-Asian Populations;JTO Clinical and Research Reports;2023-10